Aortic Valve Stenosis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Aortic Valve Stenosis

What is the definition of Aortic Valve Stenosis?
Aortic valve stenosis (AVS) is a condition characterized by narrowing of the heart's aortic valve opening. This narrowing prevents the valve from opening fully, which obstructs blood flow from the heart into the aorta, and onward to the rest of the body. AVS can range from mild to severe. Signs and symptoms typically develop when the narrowing of the opening is severe and may include chest pain (angina) or tightness; shortness of breath or fatigue (especially during exertion); feeling faint or fainting; heart palpitations; and heart murmur. Individuals with less severe congenital AVS (present at birth) may not develop symptoms until adulthood. Individuals with severe cases may faint without warning. AVS can have several causes including abnormal development before birth (such as having 1 or 2 valve leaflets instead of 3); calcium build-up on the valve in adulthood; and rheumatic fever.
What are the alternative names for Aortic Valve Stenosis?
  • Aortic valve stenosis
  • Aortic stenosis
  • Valvular aortic stenosis
Who are the top Aortic Valve Stenosis Local Doctors?
Elite in Aortic Valve Stenosis
Interventional Cardiology
Elite in Aortic Valve Stenosis
Interventional Cardiology
Referral may be required

Aurora Cardiovascular Services

960 N 12th St, 
Milwaukee, WI 
Languages Spoken:
English
Offers Telehealth

Tanvir Bajwa is an Interventional Cardiologist practicing medicine in Milwaukee, Wisconsin. Dr. Bajwa is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Patent Foramen Ovale, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Bajwa is board certified in American Board Of Internal Medicine, Cardiovascular Disease.

Elite in Aortic Valve Stenosis
Elite in Aortic Valve Stenosis
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
Experience:
28+ years
Languages Spoken:
English
Offers Telehealth

Amar Krishnaswamy is a Cardiologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 28 years. Dr. Krishnaswamy is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Aortic Regurgitation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Krishnaswamy is board certified in American Board Of Internal Medicine, 2012.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Aortic Valve Stenosis
Elite in Aortic Valve Stenosis
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
Languages Spoken:
English
Offers Telehealth

Brian Griffin is a Cardiologist practicing medicine in Cleveland, Ohio. Dr. Griffin is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. He is also highly rated in 69 other conditions, according to our data. His clinical expertise encompasses Aortic Regurgitation, Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Griffin is board certified in American Board Of Internal Medicine, 1993.

What are the latest Aortic Valve Stenosis Clinical Trials?
HeartR™ PDA Occluder Post-Market Follow-Up Study

Summary: The HeartR™ PDA Occluder Post-Market Clinical Follow-up (PMCF) Study is a multi-center, retrospective, single-arm study sponsored by Lifetech Scientific (Shenzhen) Co., Ltd., aiming to evaluate the long-term safety and performance of the Lifetech HeartR™ PDA Occluder in real-world clinical practice in Indonesia. A total of 140 subjects diagnosed with Patent Ductus Arteriosus (PDA) and treated with...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Study of the Prognosis of Infectious Endocarditis (EPEI): Prospective and Retrospective Follow-up of a Cohort of Patients Hospitalized for Infectious Endocarditis

Summary: Infectious endocarditis (IE) is the localization and proliferation of blood-borne germs in the endocardium. It remains a complicated disease to manage due to its low incidence, diagnostic difficulties, the change in epidemiology in recent decades and high mortality rates. The annual incidence is estimated at 3-10 cases per 100,000 people. The epidemiology of AR has changed significantly in recent ...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center